» Articles » PMID: 10807586

C5b-9 Membrane Attack Complex Mediates Endothelial Cell Apoptosis in Experimental Glomerulonephritis

Overview
Specialties Nephrology
Physiology
Date 2000 May 12
PMID 10807586
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

We studied the role of the C5b-9 membrane attack complex in two models of inflammatory glomerulonephritis (GN) initiated by acute glomerular endothelial injury in Piebold-viral-Glaxo (PVG) complement-sufficient rats (C+), C6-deficient rats (C6-), and rats systematically depleted of complement with cobra venom factor (CVF). GN was induced by performing a left nephrectomy and selectively perfusing the right kidney with either 1) the lectin concanavalin A (Con A) followed by complement-fixing anti-Con A (Con A GN) or 2) purified complement-fixing goat anti-rat glomerular endothelial cell (GEN) antibody [immune-mediated thrombotic microangiopathy (ITM)]. Comparable levels of GEN apoptosis were detected in C+ animals in both models. CVF administration reduced GEN apoptosis by 10- to 12-fold. GEN apoptosis was C5b-9 dependent because PVG C6- rats were protected from GEN loss. Furthermore, functional inhibition of the cell surface complement regulatory protein CD59 by renal perfusion with anti-CD59 antibody in ITM resulted in a 3.5-fold increase in GEN apoptosis. Last, in Con A GN, abrogation of GEN apoptosis preserved endothelial integrity and renal function. This study demonstrates the specific role of C5b-9 in the induction of GEN apoptosis in experimental inflammatory GN, a finding with implications for diseases associated with the presence of antiendothelial cell antibodies.

Citing Articles

Double-Edged Sword: Exploring the Mitochondria-Complement Bidirectional Connection in Cellular Response and Disease.

Lin J, Hwang S, Luo H, Mohamud Y Biology (Basel). 2024; 13(6).

PMID: 38927311 PMC: 11200454. DOI: 10.3390/biology13060431.


The Role of Complement Dysregulation in Glaucoma.

Hoppe C, Gregory-Ksander M Int J Mol Sci. 2024; 25(4).

PMID: 38396986 PMC: 10888626. DOI: 10.3390/ijms25042307.


Unleashing the power of complement activation: unraveling renal damage in human anti-glomerular basement membrane disease.

Tang A, Zhao X, Tao T, Xie D, Xu B, Huang Y Front Immunol. 2023; 14:1229806.

PMID: 37781380 PMC: 10540768. DOI: 10.3389/fimmu.2023.1229806.


Complement C6 deficiency exacerbates pathophysiology after spinal cord injury.

Su D, Hooshmand M, Galvan M, Nishi R, Cummings B, Anderson A Sci Rep. 2020; 10(1):19500.

PMID: 33177623 PMC: 7659012. DOI: 10.1038/s41598-020-76441-3.


Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model.

Reinehr S, Gomes S, Gassel C, Asaad M, Stute G, Schargus M Front Pharmacol. 2019; 10:1381.

PMID: 31849650 PMC: 6901014. DOI: 10.3389/fphar.2019.01381.